News – SmiLe Venture Hub

2025-05-16 09:47Press release

MedVasc raises SEK 10 Million to accelerate final development and FDA preparation for Solutio™ device

MedVasc AB has successfully closed a SEK 10 million financing round. The funding supports the company’s final product development phase and preparation for FDA regulatory approval in the United States.

2025-05-06 08:20Press release

RECCAN AB Secures SEK 7 Million Investment to Advance Groundbreaking Pancreatic Cancer Test Towards Market

RECCAN AB has secured SEK 7 million through a directed share issue, with Sandberg Development as the lead investor. The capital will fund clinical validation and verification of production processes ahead of CE marking and a European launch.

2025-04-16 14:56News

Open Call for Applications to Support Cellular Agriculture Innovators Entering the EU Market

APROVALS (Accelerating PROteins innoVAtion beyond reguLatory Sandboxes), a EU-funded initiative, is dedicated to advancing regulatory innovation in cellular agriculture, particularly cell-grown meat. We invite companies aiming to enter the European market to apply from April 14 to June 9, 2025.

2025-04-14 12:05Press release

SmiLe Strengthens Global Life Science Innovation by Supporting the Launch of Finnish OYSTER Incubator

SmiLe Venture Hub is supporting the development and launch of the new OYSTER Incubator, designed to accelerate health and life science innovation in Finland.

2025-04-07 15:29News

Apply for the Servier Golden Ticket 2025 – a unique opportunity to accelerate your research and development efforts

Applications are now open for the Servier Golden Ticket – a program sponsored by Servier in collaboration with SmiLe Venture Hub, designed to support promising startup in oncology and neuroscience, developing groundbreaking therapeutics, platform technologies or AI/ML data-driven platforms for drug discovery.

2025-03-31 11:50Press release

Capillon Analytics Paves the Way for Early Cancer Diagnosis Through Hair Analysis

The new SmiLe company Capillon Analytics is developing an innovative method for early cancer detection based on hair analysis. Using an AI-driven technology that identifies chemical signatures in hair strands, their method has the potential to revolutionize early detection of cancer.

2025-03-27 11:05Press release

New SmiLe company Strike Pharma develops next-generation precision medicine

New SmiLe company Strike Pharma has developed a technology platform that enables the selective delivery of drugs, enclosed in nanoparticles, to specific cells in the body. With this innovation, immune cells can be reprogrammed inside the body (in vivo).

2025-02-14 08:20Press release

Zeiss Becomes a New Lab Partner for SmiLe Venture Hub

SmiLe has entered into a partnership with Zeiss, a leading company in the development, manufacturing, and marketing of optical instruments. Zeiss has delivered three new microscopes and upgraded several existing ones.

2025-02-12 08:10News

SmiLe welcomes Magnhild Owman as the new People & Culture coach

SmiLe Venture Hub strengthens its support to startups by welcoming Magnhild Owman as the new People & Culture coach. With over 20 years of experience in recruitment and organizational development, she will support SmiLe's companies in leadership, corporate culture, and recruitment strategy matters.

2025-02-06 12:20Press release

New Technology from Emulsi Biotech Can Make Biological Drugs More Effective

The new SmiLe company Emulsi Biotech is developing a groundbreaking platform technology for the oral delivery of drugs. Their innovative NanoLIPID platform has the potential to protect drug substances, enable slow release, and significantly enhance the body's absorption of medications.

2025-01-29 15:09Press release

SmiLe Venture Hub takes a role in shaping the future of sustainable food through APROVALS, a significant European collaboration

We are join forces with seven prominent European agri-foodtech innovation clusters in the project to accelerate the deployment of emerging technologies in cellular agriculture

2025-01-24 10:25Press release

SmiLe Inject Capital invests 3 million SEK in Xaga Surgical

Medical technology company Xaga Surgical raises a total of 8 million SEK in an investment round, with SmiLe Inject Capital contributing 3 million SEK. Xaga Surgical develops innovative medical needles to reduce the risk of infections and improve cancer diagnostics.

2025-01-17 12:37News

SmiLe recruits Malin Sjöö to strengthen support for foodtech companies

SmiLe Venture Hub is pleased to welcome Malin Sjöö back to SmiLe as she assumes the newly established role of Chief Innovation Officer. Malin Sjöö will be responsible for further developing SmiLe’s foodtech operations and leading the work of the coaching team.

2025-01-14 08:20Press release

Xinnate receives Orphan Drug Designation from US FDA for TCP-25

Xinnate receives Orphan Drug Designation from US FDA for TCP-25, the company's drug candidate for the treatment of the severe disease Epidermolysis Bullosa (EB).

2025-01-10 08:35Press release

Bio-Rad joins SmiLe Venture Hub as new lab partner

Bio-Rad joins SmiLe Venture Hub as new lab partner. Through this partnership, Bio-Rad’s state-of-the-art QX600™ AutoDG Droplet Digital PCR System is now available to companies using SmiLe’s laboratories in Lund.

2024-12-18 08:30Press release

Dx4Life secures funding ahead of launch of its groundbreaking rapid test for IVF treatments

The SmiLe company Dx4Life has completed a new share issue, raising 6.4 million SEK to prepare for the launch of a unique rapid test that is set to significantly increase the success rate of IVF treatments.

2024-12-16 11:10News

Advancing Health Data Innovation with Data Lake

Region Skåne and SmiLe Venture Hub are collaborating on the "Data Lake" project with the long-term goal to create a secure health data repository, aimed at improving healthcare and fostering innovation.

2024-12-12 08:15Press release

Xinnate AB partners with Destum Partners, Inc. to accelerate partnership activities for TCP-25 as treatment for EB

Xinnate AB has a strategic collaboration with Destum Partners, Inc., an advisory firm specializing in the life sciences sector. Destum Partners will act as the exclusive advisor to Xinnate AB for identifying and developing partnership opportunities for TCP-25 gel, for the treatment of Epidermolysis Bullosa

2024-11-11 13:01Press release

Greenfood and Tekinn to Transform Vegetable Scraps into Nutritious Raw Material

SmiLe company Tekinn, together with Greenfood, one of the Nordic region's leading groups in healthy food, has received support from Vinnova to turn 400 tons of cabbage scraps into nutritious raw material using fermentation, with the potential to reshape the map for future food systems and their waste streams.

2024-11-04 08:15Press release

Aligned Bio secures SEK 19.4 million to scale up its groundbreaking nanowire technology

SmiLe company Aligned Bio has successfully completed a financing round, securing SEK 19.4 million to accelerate the development and scale up its nanowire production technology. The company has been accepted into the SmiLe incubator program.

2024-10-31 13:00Press release

Ulrika Ringdahl new CEO of SmiLe Venture Hub

SmiLe Deputy CEO Ulrika Ringdahl takes over as new CEO of SmiLe. She succeeds Ebba Fåhraeus who after ten years has announced that she wishes to leave the CEO role.

2024-10-21 12:30Press release

QIAGEN is New Lab Partner for SmiLe Venture Hub

QIAGEN is a new Lab Partner for SmiLe Venture Hub. Through this partnership, QIAGEN has generously equipped our laboratories with its advanced QIAcuity, a digital PCR (dPCR) instrument.

2024-10-02 10:56Press release

AAX Biotech Secures Funding to Drive Technology Development and Expansion

SmiLe company AAX Biotech AB has successfully raised 7 MSEK in a funding round backed by both new and existing investors. The capital will be used to support the company’s ongoing growth and innovation efforts, strengthening its internal capabilities and expanding its project portfolio.

2024-09-06 14:10Press release

Xinnate presents TCP-25 data at international dermatology congress

Xinnate presents TCP-25 data at international dermatology congress. The company is developing therapies based on a pioneering immune-modulating peptides technology, targets dysfunctional healing, including treatment of the genetic disorder Epidermolysis Bullosa.

2024-09-02 12:35Press release

New Diagnostics for Stroke and Heart Attack to Revolutionize Healthcare

The SmiLe company Medqus Innovations is introducing a groundbreaking technology for the diagnosis of stroke and heart attack. The new technology analyzes the tissue content of constrictions in the carotid arteries, something that current methods in clinics are unable to do.

2024-08-29 08:30Press release

SmiLe Inject Capital Invests 9 Million SEK in Three Groundbreaking Life Science Startups

SmiLe Inject Capital, an investment company under the SmiLe Venture Hub umbrella, is investing a total of 9 million SEK (0,8 million euros) in three promising life science startups: Uman Sense, Nygen Analytics, and Aligned Bio. All three companies are members of SmiLe.

2024-08-27 08:20Press release

New High-Profile Additions to SmiLe's Board of Directors

SmiLe welcomes Anders Sundström, politician and business leader, and Professor Annika Olsson, Dean of the Faculty of Engineering at Lund University, as new members of its Board of Directors. Their extensive experience in politics, business, research, and academia will further strengthen SmiLe.

2024-08-21 12:35Press release

First Iron Product for Food Fortification That Can Reduce the Iron Deficiency Epidemic

The new SmiLe company Ironic Biotech is developing an entirely new form of easily absorbed iron. This iron could become the first commercially available iron product for fortifying foods without causing rancidity or metallic taste. Ironic Biotech is opening a seed investment round this fall

2024-06-27 09:40Press release

Transient Pharma AB attracts SEK 16 million in investments through an oversubscribed new share issue.

Lund, Sweden, 27 June 2024 - Transient Pharma AB has secured 16 million SEK in funding from SmiLe Inject Capital AB and private investors to advance the pre-clinical development of their novel drug concept.

2024-06-20 08:20Press release

SmiLe Strengthens Foodtech Expertise

SmiLe Strengthens Foodtech Expertise with Katharina Björnek as a new coach with foodtech expertise. Her broad experience in product development and quality assurance in the food sector on a global level will contribute to the rapid development of our incubator companies.

2024-04-16 08:50News

New Advisor with International Expertise Joins SmiLe's Coaching Team

SmiLe is strengthening its team with additional expertise in global business operations and entrepreneurship, and we are delighted to welcome Michael Palm as a senior advisor.

2024-02-16 15:47News

Suturion secures 24 million for the upcoming launch

SmiLe Incubator company Suturion secures 24 million for the upcoming launch. Suturion has developed a medical instrument designed to reduce complications and enhance patient safety following open abdominal surgery.

2023-11-27 13:14News

Incubator company Manje Health signs contract to digitalize Ghana’s Medical Ecosystem

Manje Health AB has signed a contract with the government of Ghana through the national insurance company SIC Life to digitalize the country’s medical ecosystem.

2023-09-06 13:23News

The SmiLe company Yazen Health raises 37 million SEK

The SmiLe company Yazen Health raises 37 million SEK and plans to develop its digital obesity clinic and continue expanding in Europe.

2022-03-30 12:59News

SmiLe strengthens the team

SmiLe Incubator strives to continuously improve its operations to help startup companies and entrepreneurs to commercialize their innovations. We are therefore pleased to welcome Barbara Klein and Jacob Lundgren, who will strengthen the team with their experience in project management and funding.

2021-05-10 09:25News

JOIN US IN DRIVING BUSINESS SUCCESS THROUGH DIVERSITY

SmiLe, invites its member companies to participate in a series of workshops by the Allbright Foundation, that aim to educate and train on how to create equal and inclusive workplaces, as a means to business success.

2021-04-30 09:13News

Innovative healthtech project kickstarts at SmiLe Bootcamp

The seventh edition of SmiLe’s ten-week program for early companies and entrepreneurs with innovative ideas and products in healthtech, medtech and eHealth is now underway. The projects address key care-related areas such as pain, psychiatric disorders and postnatal problems.

2021-04-07 13:33News

Celebrating 13 SmiLe companies fighting cancer

Today we celebrate UN World Health Day by paying tribute to 13 awesome SmiLe companies fighting cancer in different ways; from early diagnosis to drug development and other advanced cancer treatment therapies.

2021-03-16 08:55News

Launch of rapid sustainability assessment for life science start-ups

Today, SmiLe announces the launch of a new rapid assessment tool – SmiLe´s SDG Scan – that makes it easy for early-stage life science businesses to measure their impact on the UN’s Sustainable Development Goals (SDGs), even if they have limited time and resources.

2021-03-08 09:22News

Join SmiLe’s charity campaign #MarchForWomen

On the occasion of International Women’s Day on March 8th, SmiLe launches, in collaboration with Skåne Stadsmission, the month-long charity ‘March for Women’ to garner support for women in need and their families.

2021-02-17 10:38News

SmiLe and the Chamber of Commerce to jointly support startup companies

SmiLe Incubator and the Chamber of Commerce and Industry have entered into a strategic partnership that provides SmiLe member companies with the benefit of accessing Chamber of Commerce and Industry member offers while the companies are at SmiLe Incubator.

2021-02-16 09:55News

Get Your Business Idea Investment‑Ready In 10 Weeks

The call for applications are officially open for the 7th batch of our SmiLe Bootcamp, formerly known as Health2B. SmiLe Bootcamp is a ten-week virtual development program designed to accelerate early-stage HealthTech, MedTech and eHealth start-ups to develop their business idea and become investment-ready.

2021-01-27 15:07News

New brand identity marks new era for SmiLe

The recent years’ transformation of SmiLe generated a need to refresh and modernize our brand visuals. Today, we are thrilled to announce the launch of our new brand identity that better reflects our expanded operations and significantly improved offering that will further benefit life science startups.

2020-12-16 10:53News

Young SmiLe entrepreneurs honored again

Young founders of SmiLe Incubator companies are honored. Alice Mattsson, has been named by Venture Cup as having one of the year’s best business ideas in southern Sweden. In addition, Maximilian Ottosson, Linn Wrangmark and Frida McCabe, along with Fábio Rosa, all qualified for the Rapidus´ "34-list".

2020-12-11 10:57News

Tomorrow’s entrepreneurs graduate from SmiLe e-Campus

The first session of SmiLe e-Campus, a training program focused on entrepreneurship in the life sciences open to participants from Europe, is coming to an end. Appreciated was SmiLe’s invaluable knowledge, and the connection to the industry through the unique collaboration with GE Healthcare and Philips Electronics.

2020-11-26 11:26News

SmiLe partners with Life Science Sweden

SmiLe is pleased to announce a new collaboration partnership with Life Science Sweden, the leading Nordic Life Science media and event organizer.

2020-11-04 15:21News

Lund-based research organisations and companies form “LundaGUARD”

“LundaGUARD” is a new consortium aimed at responding to present and future threats from infectious agents. The consortium consists of public and private organisations: SARomics Biostructures AB and Red Glead Discovery AB (two SmiLe alumni companies), LP3 at Lund University, MAX IV, ESS and UCL School of Pharmacy.

2020-10-29 15:49News

4 inspiring CEOs, 4 professional journeys

As we are wrapping up this month’s core value focus “Professional”, we would like to put the spotlight on four of our talented CEO’s. Kristina Masson, Mohamad Takwa, Hanna Sjöström and Maximilian Ottosson talk about their professional journeys, and share their top-3 tips for other young and aspiring entrepreneurs.

2020-08-28 16:47News

SmiLe – from turnaround case to recognized brand in 5 years

During the five years that Ebba Fåhraeus has been CEO of SmiLe, the life science incubator has transformed into a ‘company generator’ with strong business focus. The success factors have been a new business model for the incubator, business focus, brand, community, IR and industry expertise in the team.

2020-08-28 12:01News

Want to “SmiLe up” with us?

Hi there, Community member! The 1st of September we´re launching SmiLe Up – aka the way we live and breathe our core values. SmiLe Up is how we do things the SmiLe way. We invite you to join us as we´re about to SmiLe Up our events, our meetings and our work.

2020-07-20 14:16News

SmiLe alumni members team up against COVID-19

SmiLe alumni members Cellevate and Redoxis continue their successful collaboration, this time focusing on the development of a 3D assay for assessing drugs for the treatment of COVID-19.

2020-07-14 15:07News

Agilent’s cutting-edge 6546 LC/Q-TOF instrument now available at SmiLe’s labs

SmiLe Incubator welcomes Agilent, a global leader in laboratory instruments, as its Diamond level Lab Sponsor. Thanks to this partnership, we can now offer our startup members, Medicon Village members and other life science startups via Open Lab Skåne, access to state of the art LC/Q-TOF technology.

2020-06-10 14:38News

CEO-coaching in collaboration with SmiLe and Almi - a great success

Through a collaboration between SmiLe and Almi, eight SmiLe companies have had the opportunity to participate in a program for CEO’s, headed by Almi Företagspartner. This is the first time Almi has put together a group consisting of only life science companies and the initiative is applauded by the participants.

2020-06-05 15:21News

Power of Smile community demonstrated as Cellevate and Redoxis team up

Yet another successful collaboration in the Smile community is established: two alumni members, Redoxis and Cellevate, team up to be able to offer optimized life science services.

2020-05-25 15:11News

Bioextrax – the 15th SmiLe alumni company to launch an IPO

The 15th SmiLe alumni company, Bioextrax, has launched an IPO and is traded on Spotligth Stock Market as of April. Bioextrax specializes in research and development of technology platforms that are used to convert organic waste into various environmentally friendly materials like bioplastics, animal feed and fibres.

2020-05-17 22:03News

SmiLe strengthens team in Marketing and People & Culture

To further strengthen the SmiLe team and provide extensive support to the incubator companies, we are pleased to introduce two new team-members: Maria Sverka, Marketing Manager, and Lena Axen Jergmo, People & Culture Coach.

Latest News

MedVasc raises SEK 10 Million to accelerate final development and FDA preparation for Solutio™ device

RECCAN AB Secures SEK 7 Million Investment to Advance Groundbreaking Pancreatic Cancer Test Towards Market

Open Call for Applications to Support Cellular Agriculture Innovators Entering the EU Market

SmiLe Strengthens Global Life Science Innovation by Supporting the Launch of Finnish OYSTER Incubator

Apply for the Servier Golden Ticket 2025 – a unique opportunity to accelerate your research and development efforts

Capillon Analytics Paves the Way for Early Cancer Diagnosis Through Hair Analysis

New SmiLe company Strike Pharma develops next-generation precision medicine

Zeiss Becomes a New Lab Partner for SmiLe Venture Hub

SmiLe welcomes Magnhild Owman as the new People & Culture coach

New Technology from Emulsi Biotech Can Make Biological Drugs More Effective

SmiLe Venture Hub takes a role in shaping the future of sustainable food through APROVALS, a significant European collaboration

SmiLe Inject Capital invests 3 million SEK in Xaga Surgical

SmiLe recruits Malin Sjöö to strengthen support for foodtech companies

Xinnate receives Orphan Drug Designation from US FDA for TCP-25

Bio-Rad joins SmiLe Venture Hub as new lab partner

Dx4Life secures funding ahead of launch of its groundbreaking rapid test for IVF treatments

Advancing Health Data Innovation with Data Lake

Xinnate AB partners with Destum Partners, Inc. to accelerate partnership activities for TCP-25 as treatment for EB

Greenfood and Tekinn to Transform Vegetable Scraps into Nutritious Raw Material

Aligned Bio secures SEK 19.4 million to scale up its groundbreaking nanowire technology

Ulrika Ringdahl new CEO of SmiLe Venture Hub

QIAGEN is New Lab Partner for SmiLe Venture Hub

AAX Biotech Secures Funding to Drive Technology Development and Expansion

Xinnate presents TCP-25 data at international dermatology congress

New Diagnostics for Stroke and Heart Attack to Revolutionize Healthcare

SmiLe Inject Capital Invests 9 Million SEK in Three Groundbreaking Life Science Startups

New High-Profile Additions to SmiLe's Board of Directors

First Iron Product for Food Fortification That Can Reduce the Iron Deficiency Epidemic

Transient Pharma AB attracts SEK 16 million in investments through an oversubscribed new share issue.

SmiLe Strengthens Foodtech Expertise

New Advisor with International Expertise Joins SmiLe's Coaching Team

Suturion secures 24 million for the upcoming launch

Incubator company Manje Health signs contract to digitalize Ghana’s Medical Ecosystem

The SmiLe company Yazen Health raises 37 million SEK

SmiLe strengthens the team

JOIN US IN DRIVING BUSINESS SUCCESS THROUGH DIVERSITY

Innovative healthtech project kickstarts at SmiLe Bootcamp

Celebrating 13 SmiLe companies fighting cancer

Launch of rapid sustainability assessment for life science start-ups

Join SmiLe’s charity campaign #MarchForWomen

SmiLe and the Chamber of Commerce to jointly support startup companies

Get Your Business Idea Investment‑Ready In 10 Weeks

New brand identity marks new era for SmiLe

Young SmiLe entrepreneurs honored again

Tomorrow’s entrepreneurs graduate from SmiLe e-Campus

SmiLe partners with Life Science Sweden

Lund-based research organisations and companies form “LundaGUARD”

4 inspiring CEOs, 4 professional journeys

SmiLe – from turnaround case to recognized brand in 5 years

Want to “SmiLe up” with us?

SmiLe alumni members team up against COVID-19

Agilent’s cutting-edge 6546 LC/Q-TOF instrument now available at SmiLe’s labs

CEO-coaching in collaboration with SmiLe and Almi - a great success

Power of Smile community demonstrated as Cellevate and Redoxis team up

Bioextrax – the 15th SmiLe alumni company to launch an IPO

SmiLe strengthens team in Marketing and People & Culture

Svenska nyheter från SmiLe

MedVasc tar in 10 MSEK för att accelerera slutförande och FDA-förberedelser för Solutio™-enheten

RECCAN AB säkrar 7 miljoner kronor för att ta deras banbrytande test för bukspottkörtelcancer närmare marknaden

SmiLe stärker global innovation inom life science genom att stödja lanseringen av den finska OYSTER-inkubatorn

Capillon Analytics banar väg för tidig cancerdiagnostik genom håranalys

Nya SmiLe-bolaget Strike Pharma utvecklar banbrytande precisionsmedicin

Zeiss blir ny labbpartner till SmiLe Venture Hub

SmiLe välkomnar Magnhild Owman som ny People & Culture coach

Ny teknik från Emulsi Biotech kan göra biologiska läkemedel mer effektiva

SmiLe Inject Capital investerar 3 miljoner kronor i Xaga Surgical

SmiLe rekryterar Malin Sjöö för att stärka stödet till foodtech-bolag

Xinnate får särläkemedelsstatus från amerikanska FDA för TCP-25

Bio-Rad blir ny labbpartner till SmiLe Venture Hub

ImmuneBiotech and Lund University Launch a Pioneering Clinical Study Linking Gut Health to Preeclampsia Prevention

ImmuneBiotech och Lunds universitet inleder banbrytande klinisk studie om tarmhälsa och havandeskapsförgiftning

Dx4Life säkrar finansiering inför lansering av sitt banbrytande snabbtest för IVF-behandlingar

Greenfood och Tekinn ska förvandla grönsaksrester till näringsrik råvara

Aligned Bio har säkrat 19,4 miljoner kronor för att skala upp sin banbrytande nanotrådsteknik

Ulrika Ringdahl ny VD för SmiLe Venture Hub

QIAGEN är ny labbpartner till SmiLe Venture Hub

AAX Biotech säkrar kapital för att främja teknikutveckling och tillväxt

Xinnate presents TCP-25 data at international dermatology congress

Xinnate presents TCP-25 data at international dermatology congress